Ray Pawson

Q: What Schools Are Affiliated With Ray Pawson

Ray Pawson is affiliated with the following schools: University of Leeds, University of Oxford

Ray Pawson's AcademicInfluence.com Rankings

Ray Pawson

Sociology

#819

World Rank

#955

Historical Rank

sociology Degrees

Download Badge

Sociology

Why Is Ray Pawson Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ray Pawson is Professor of Social Research Methodology in the School of Sociology and Social Policy at the University of Leeds. Pawson's main interest lies in research methodology. He has written widely on the philosophy and practice of research, covering methods qualitative and quantitative, pure and applied, contemporaneous and historical. He is the author of 'Realist Synthesis', a new approach of literature review that, in the last years, has widely influenced systematic review practices of complex programmes and policies all over the world.

(See a Problem?)

Ray Pawson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. (1997) (200)
Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG ± Ida) and second allogeneic stem cell transplant (2001) (68)
Mycosis fungoides and Sezary syndrome are not associated with HTLV‐I infection: an international study (1997) (64)
The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia (1997) (55)
MANAGEMENT OF ADULT T‐CELL LEUKAEMIA/LYMPHOMA (1998) (50)
Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee (2014) (41)
UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high‐dose chemoradiotherapy for patients with malignancy (2018) (38)
Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia? (1997) (33)
Second malignancy in hairy cell leukaemia: no evidence of increased incidence after treatment with interferon alpha. (1996) (30)
HTLV-I associated primary CNS T-cell lymphoma (1998) (28)
Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases. (1996) (27)
Lack of evidence of HHV-8 in mature T-cell lymphoproliferative disorders (1996) (24)
HTLV-I screening in Britain (1995) (19)
Prevention of transfusion‐transmitted cytomegalovirus (CMV) infection: Standards of care (2014) (17)
Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow) (2011) (15)
ANCA +ve vasculitis after autologous PBSC transplantation. (2002) (10)
Attrition at the final donor stage among unrelated haematopoietic stem cell donors: the British Bone Marrow Registry experience (2019) (8)
Absence of HTLV‐I/II in T‐prolymphocytic leukaemia (1998) (7)
Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvest (2014) (5)
Absence of Bartonella-like inclusions in microangiopathy after transplantation (1998) (5)
HTLV-1 associated primary CNS T-cell lymphoma (vol 158, pg 226, 1998) (1999) (4)
Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation. (2019) (4)
Developing a dedicated dermatology service for allogeneic bone marrow transplant recipients (2017) (3)
SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry (2021) (3)
The use of defibrotide in the management of vascular endothelial complications (VOD/HUS/TTP) of stem cell transplantation. (1999) (3)
Type 1 cryoglobulinaemia leading to gangrene of the toes and ischaemic ulceration (2018) (3)
Predicting the availability of haematopoietic stem cell donors using machine learning. (2020) (2)
Malignancy: Human T-Cell Lymphotropic Virus Type I and Adult T-Cell Leukaemia/Lymphoma. (1999) (1)
Predicting the Availability of Hematopoietic Stem Cell Donors Using Machine Learning (2020) (1)
Banking on cord blood. (2014) (1)
Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening (2019) (0)
Salvage chemotherapy and donor lymphocyte infusion induces durable remissions in AML relapsing following allogeneic stem cell transplantation (2018) (0)
Multi-Centre UK Study of Allogeneic Haematopoietic Stem Cell Graft Cryopreservation Effects on Patient Outcomes (2022) (0)
Lymphoproliferative disorders of mature T cells : studies on clinicopathological characteristics and aetiology. (1998) (0)
Therapy at adult T-cell leukaemia/lymphoma: Experience of two London hospitals (1996) (0)
Use and Efficacy of Stem Cells Cryopreserved for More Than One Year. (2006) (0)
Prevalence of Sars-Cov-2 in Stem Cell Donors from Anthony Nolan UK Stem Cell Registry: Sars-Cov-2 Testing Programme, Impact on Stem Cell Collections and Managing Risk Going Forward (2022) (0)
An audit of BCSH guidelines: Are we minimising the risk of transfusion-associated graft-versus-host-disease? (2012) (0)
Combined foscarnet and ganciclovir at half doses for the pre-emptive treatment of CMV infection: A pilot study. (1999) (0)
RICE/ICE Is an Effective PBSC Mobilising Regime in Patients with Aggressive Lymphoma. (2005) (0)

This paper list is powered by the following services:

Other Resources About Ray Pawson

What Schools Are Affiliated With Ray Pawson?

Ray Pawson is affiliated with the following schools: